Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 388.36 Million SAR | 11.35% |
| 2022 | 350.61 Million SAR | 21.37% |
| 2021 | 288.89 Million SAR | 5.67% |
| 2020 | 273.38 Million SAR | 11.63% |
| 2019 | 244.89 Million SAR | -8.08% |
| 2018 | 266.42 Million SAR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 98.74 Million SAR | -13.33% |
| 2024 Q1 | 122.81 Million SAR | 60.13% |
| 2024 Q2 | 113.92 Million SAR | -7.24% |
| 2023 Q4 | 76.7 Million SAR | -22.01% |
| 2023 FY | 390.4 Million SAR | 11.35% |
| 2023 Q3 | 98.34 Million SAR | -3.88% |
| 2023 Q2 | 102.31 Million SAR | -2.31% |
| 2023 Q1 | 104.73 Million SAR | 30.92% |
| 2022 Q2 | 95.45 Million SAR | 10.35% |
| 2022 Q1 | 86.49 Million SAR | 19.42% |
| 2022 FY | 350.61 Million SAR | 21.37% |
| 2022 Q4 | 80 Million SAR | -9.86% |
| 2022 Q3 | 88.75 Million SAR | -7.02% |
| 2021 FY | 288.89 Million SAR | 5.67% |
| 2021 Q4 | 72.43 Million SAR | 0.0% |
| 2021 Q3 | 72.43 Million SAR | -3.46% |
| 2021 Q2 | 75.02 Million SAR | 5.86% |
| 2021 Q1 | 70.87 Million SAR | 0.0% |
| 2020 FY | 273.38 Million SAR | 11.63% |
| 2019 FY | 244.89 Million SAR | -8.08% |
| 2018 FY | 266.42 Million SAR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | 645 Million SAR | 39.789% |